Schedule 13D ownership disclosure

SATSUMA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 80405P107

Event date: 2023-04-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-103637
Form type
SC 13D/A
Filer
Satsuma Pharmaceuticals, Inc.
CIK
CIK 1692830
Filed
Apr 17, 2023
Reporting period
Apr 16, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub